(Q51764521)

English

EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies.

scientific article published on 17 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies. (English)

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

1 reference

based on heuristic

inferred from title

Maryalice Stetler-Stevenson

3

object named as

Maryalice Stetler-Stevenson

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Stefania Pittaluga

7

object named as

Stefania Pittaluga

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Thomas Waldmann

13

object named as

Thomas A Waldmann

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

author name string

Deirdre O'Mahony

1

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

John C Morris

2

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Helen Matthews

4

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Margaret R Brown

5

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Thomas Fleisher

6

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Mark Raffeld

8

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Paul S Albert

9

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Dirk Reitsma

10

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Karen Kaucic

11

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Luz Hammershaimb

12

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

John E Janik

14

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

language of work or name

0 references

publication date

17 March 2009

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Clinical Cancer Research

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

15

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

7

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

2514-2522

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Epstein-Barr virus positive large B-cell lymphoma arising in a patient previously treated with Cladribine for hairy cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epstein-Barr virus–associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant lymphomas in transplantation patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immune response to primary EBV infection: a role for natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epstein-Barr virus-positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An anti-CD2 monoclonal antibody that both inhibits and stimulates T cell activation recognizes a subregion of CD2 distinct from known ligand-binding sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoproliferative disorders in renal transplant patients in Japan.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporin A and Epstein-Barr virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttransplant lymphoproliferative disease: a series of 23 cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttransplantation lymphoproliferative disorders (PTLD): current perspectives.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD2 regulates the positive selection and function of antigen-specific CD4- CD8+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-transplant lymphoproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel murine model for the assessment of human CD2-related reagents in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

https://pubmed.ncbi.nlm.nih.gov/19293260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-08-1254

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

0 references

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19293260

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51764521&oldid=1984682117"